mercaptopurine and Cleft-Palate

The present study analyzes the morphological, histochemical, and ultrastructural aspects of the pathogenesis of 6-mercaptopurine (6MP)-induced cleft palate in hamster fetuses. Gross and light microscopic observations indicated that 6MP stunts the growth of vertical palatal shelves and thus induces cleft palate. Ultrastructural analysis showed that, in contrast to controls, 6MP-induced alterations were first seen in the mesenchymal cells 24 hr after drug administration. The initial alterations were characterized by swelling of the nuclear membrane. During the next 12 hr, lysosomes were seen first in the mesenchymal cells and then in the cells of the medial edge epithelium (MEE) of the developing palatal primordia. The appearance of lysosomes was temporally abnormal and was interpreted as a sublethal response to 6MP treatment. Subsequently, the nuclear alterations and the lysosomes diminished; and 48 hr after 6MP administration, they were absent from the palatal tissues. Ninety hours after 6MP administration, unlike the controls (in which the palatal shelves were already fused), changes were seen at the epithelial-mesenchymal interface in the developing cleft palatal shelves. These changes were characterized by breakdown of the basal lamina and epithelial-mesenchymal contacts. Eventually, at term, the MEE of the vertical shelf stratified. It was suggested that 6MP affected cytodifferentiation in the palatal tissues during the critical phase of early vertical shelf development and thereby induced cleft palate.

Topics: Acid Phosphatase; Animals; Cleft Palate; Cricetinae; Female; Gestational Age; Mercaptopurine; Mesocricetus; Morphogenesis; Pregnancy

Topics: Abnormalities, Drug-Induced; Animals; Cleft Lip; Cleft Palate; Cyclophosphamide; Dental Pulp Diseases; Embryo, Mammalian; Female; Fetus; Gestational Age; Maxilla; Mercaptopurine; Micrognathism; Nose Deformities, Acquired; Odontogenic Cysts; Pregnancy; Rats; Skull; Tooth Abnormalities; Tooth Germ